US Long Covid 20% of cases

Which is way higher than the UK figure CDC, Long covid Latest UK figures https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19latestinsights/infections 2.8% of the population, self-reported Of those, 73% symptoms at least 12 weeks 44% symptoms at least one year Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021 https://www.cdc.gov/mmwr/volumes/71/wr/mm7121e1.htm?s_cid=mm7121e1_e&ACSTrackingID=USCDC_921-DM82414&ACSTrackingLabel=MMWR%20Early%20Release%20-%20Vol.%2071%2C%20May%2024%2C%202022&deliveryName=USCDC_921-DM82414#contribAff Previously infected with SARS-CoV-2, reported persistent symptoms ≥4 weeks after acute COVID-19 March 2020–November 2021 United States, aged ≥18 Incidence of 26 conditions often / previously attributable to post-COVID Among all patients aged ≥18 years 38% of case-patients experienced an incident condition 16% of controls 18–64 years 35.4% of case-patients experienced at least one incident condition 14.6% of controls experienced at least one incident condition Aged ≥65 years 45.4% of case-patients experienced at least one incident condition 18.5% of controls experienced at least one incident condition. Survivors aged 18–64 One in 5 Survivors aged ≥65 One in 4 experiencing an incident condition that might be attributable to previous COVID-19 Conditions affected multiple systems cardiovascular, pulmonary, hematologic, renal, endocrine, gastrointestinal, musculoskeletal, neurologic, and psychiatric signs and symptoms Highest risk ratios (RRs) Acute pulmonary embolism 18 to 64, RR = 2.1 ≥65, RR = 2.1 RR = 2.1 and 2.2 among persons aged 18–64 and ≥65 years, respectively) and Respiratory signs and symptoms RR = 2.1 in both age groups Critical to reducing the incidence and impact of post-COVID Implementation of COVID-19 prevention strategies Routine assessment for post-COVID conditions is critical to reducing the incidence and impact of post-COVID The research study A retrospective matched cohort design March 2020–November 2021 63.4 million unique adult records 110 data contributors in the 50 states Case-patients, 353,164 Control patients, 1,640,776 Case-patients or control patients with a previous history of one of the included conditions were excluded No significant difference Cerebrovascular disease Mental health conditions Substance-related disorders Differences by age group were noted RR for cardiac dysrhythmia 18 to 64, RR = 1.7 ≥65, RR = 1.5 Musculoskeletal pain 18–64, RR = 1.6 ≥65, RR = 1.4 RRs for 10 incident conditions, significantly higher among those aged ≥65 Renal failure, thromboembolic events, cerebrovascular disease, type 2 diabetes, muscle disorders, neurologic conditions, and mental health conditions (including mood disorders, anxiety, other mental conditions, and substance-related disorders Limitations Patients infected with recent variants Acute COVID-19 infection might be biased toward a population that is seeking care COVID-19 vaccination status was not considered in this analysis Learn more about your ad choices. Visit megaphone.fm/adchoices